Cigna Group $CI Position Decreased by NewEdge Wealth LLC

NewEdge Wealth LLC reduced its holdings in Cigna Group (NYSE:CI) by 27.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,667 shares of the health services provider’s stock after selling 2,148 shares during the quarter. NewEdge Wealth LLC’s holdings in Cigna Group were worth $1,512,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CI. Assetmark Inc. increased its stake in Cigna Group by 10.0% in the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after purchasing an additional 5,963 shares in the last quarter. apricus wealth LLC boosted its holdings in shares of Cigna Group by 715.9% in the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after buying an additional 8,340 shares during the period. Nisa Investment Advisors LLC increased its position in shares of Cigna Group by 3.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 105,534 shares of the health services provider’s stock worth $29,046,000 after acquiring an additional 3,814 shares in the last quarter. OFI Invest Asset Management raised its holdings in shares of Cigna Group by 8,357.8% during the fourth quarter. OFI Invest Asset Management now owns 33,070 shares of the health services provider’s stock valued at $9,102,000 after acquiring an additional 32,679 shares during the period. Finally, Polianta Ltd acquired a new stake in shares of Cigna Group during the fourth quarter valued at approximately $1,568,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Barclays lowered shares of Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $310.00 to $304.00 in a research note on Tuesday, May 26th. Piper Sandler reduced their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Sanford C. Bernstein raised their target price on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, June 20th. Finally, Robert W. Baird set a $337.00 price target on Cigna Group in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Cigna Group Stock Performance

Shares of CI opened at $290.06 on Monday. The company has a market capitalization of $76.73 billion, a PE ratio of 12.30, a PEG ratio of 1.12 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The company’s 50 day moving average price is $286.05 and its 200 day moving average price is $280.76. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts expect that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.